Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 28898378)

Published in JAMA on September 12, 2017

Authors

JoAnn E Manson1, Aaron K Aragaki2, Jacques E Rossouw3, Garnet L Anderson2, Ross L Prentice2, Andrea Z LaCroix4, Rowan T Chlebowski5,6, Barbara V Howard7,8, Cynthia A Thomson9, Karen L Margolis10, Cora E Lewis11, Marcia L Stefanick12, Rebecca D Jackson13, Karen C Johnson14, Lisa W Martin15, Sally A Shumaker16, Mark A Espeland17, Jean Wactawski-Wende18, WHI Investigators

Author Affiliations

1: Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
3: National Heart, Lung, and Blood Institute, Bethesda, Maryland.
4: Department of Family Medicine and Public Health, University of California, San Diego, School of Medicine, San Diego.
5: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance.
6: now with City of Hope National Medical Center, Department of Medical Oncology and Therapeutics Research, Duarte, California.
7: MedStar Health Research Institute, Washington DC.
8: Georgetown/Howard Universities Center for Clinical and Translational Sciences, Washington DC.
9: Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson.
10: HealthPartners Institute for Education and Research, Minneapolis, Minnesota.
11: Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham.
12: Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California.
13: Department of Medicine, The Ohio State University, Columbus.
14: Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis.
15: Cardiology Division, George Washington University School of Medicine and Health Sciences, Washington DC.
16: Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
17: Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina.
18: Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, New York.

Associated clinical trials:

Women's Health Initiative (WHI) | NCT00000611

Articles by these authors

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26

Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA (2006) 3.29

Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. JAMA Oncol (2015) 3.13

Vitamin D research and clinical practice: at a crossroads. JAMA (2015) 2.55

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40

Risks and benefits of antihypertensive medications in older adults. JAMA Intern Med (2014) 1.12

Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study. Am J Cardiol (2004) 1.07

Patients affected by changes to hypertension guideline. JAMA (2014) 1.06

Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat (2007) 1.01

Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr (2009) 0.88

Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol A Biol Sci Med Sci (2014) 0.84

Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial. Cancer Epidemiol Biomarkers Prev (2014) 0.83

Use of a urinary sugars biomarker to assess measurement error in self-reported sugars intake in the nutrition and physical activity assessment study (NPAAS). Cancer Epidemiol Biomarkers Prev (2014) 0.83

Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med (2016) 0.82

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med (2014) 0.82

The Potential for Postrandomization Confounding in Randomized Clinical Trials. JAMA (2016) 0.79

Newly Developed Chronic Conditions and Changes in Health-Related Quality of Life in Postmenopausal Women. J Am Geriatr Soc (2015) 0.79

Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2016) 0.78

Relation of longitudinal changes in body mass index with atherosclerotic cardiovascular disease risk scores in middle-aged black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Ann Epidemiol (2016) 0.78

Obesity and Structural Brain Integrity in Older Women: The Women's Health Initiative Magnetic Resonance Imaging Study. J Gerontol A Biol Sci Med Sci (2016) 0.78

Cost-effectiveness of the LIFE Physical Activity Intervention for Older Adults at Increased Risk for Mobility Disability. J Gerontol A Biol Sci Med Sci (2016) 0.78

Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev (2015) 0.78

Hormone therapy use and outcomes in the Women's Health Initiative trials--reply. JAMA (2014) 0.77

Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci (2016) 0.77

NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prev Res (Phila) (2015) 0.77

Concurrent and longitudinal relationships between cognitive activity, cognitive performance, and brain volume in older adult women. J Gerontol B Psychol Sci Soc Sci (2014) 0.77

The Relationship of Cardiovascular Disease to Physical Functioning in Women Surviving to Age 80 and Above in the Women's Health Initiative. J Gerontol A Biol Sci Med Sci (2016) 0.76

Vitamin D insufficiency and abnormal hemoglobin a1c in black and white older persons. J Gerontol A Biol Sci Med Sci (2014) 0.76

Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Res (2016) 0.76

The Evolution of the WHI 80+ Cohort. J Gerontol A Biol Sci Med Sci (2015) 0.76

Vasomotor symptom duration in midlife women--research overturns dogma. JAMA Intern Med (2015) 0.76

Factors Associated With Adherence to Blood Pressure Measurement Recommendations at Pediatric Primary Care Visits, Minnesota and Colorado, 2007-2010. Prev Chronic Dis (2015) 0.75

Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med (2017) 0.75

Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2015) 0.75

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. J Am Soc Nephrol (2016) 0.75

Cognitive Function and Changes in Cognitive Function as Predictors of Incident Cardiovascular Disease: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci (2017) 0.75

Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med (2017) 0.75

Aging Well: Observations From the Women's Health Initiative Study. J Gerontol A Biol Sci Med Sci (2016) 0.75

Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med (2017) 0.75

Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial. JAMA Intern Med (2017) 0.75

Reconciling the divergent findings from clinical trials and observational studies of menopausal hormone therapy for prevention of coronary heart disease. Semin Reprod Med (2014) 0.75

Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative. J Am Coll Cardiol (2017) 0.75

Clinical Trials Targeting Aging and Age-Related Multimorbidity. J Gerontol A Biol Sci Med Sci (2017) 0.75

Estrogen and colorectal cancer incidence and mortality. Cancer (2015) 0.75

Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups. J Gerontol A Biol Sci Med Sci (2017) 0.75